Andrew Hollman Meyer

Chief Business Officer

Andrew Hollman Meyer (Chief Business Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in JANX. The largest single filing was $501K of JANX (16,665 sh × $30.06, as filed), executed Oct 28 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$501K

shares × price, as filed

Last traded

Oct 28 2025

Filed Oct 30 2025

Open performance→

Volume by month

Buys $0 Sells $1.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 1 filing

Sector per market data · by filing · past 12 months

Most traded names

JANX JANX JANX · 0 buys · 5 sells 5 filings

Recent filings

JANXSALE Janux Therapeutics, Inc. View filing → $501K
16,665 sh × $30.06
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. View filing → $100K
3,334 sh × $30.00
Exec Apr 21 2025
Filed Apr 23 2025 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. View filing → $102K
2,418 sh × $42.08
Exec Feb 3 2025
Filed Feb 5 2025 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. View filing → $664K
12,134 sh across 3 lots
Exec Jan 2 2025
Filed Jan 3 2025 · 5:30 PM ET JANXSALE Janux Therapeutics, Inc. View filing → $2.3M
50,000 sh × $45.96
Exec Sep 27 2024
Filed Sep 27 2024 · 5:30 PM ET